Animal Health Market Anticipated to Achieve $89.4 Billion by 2030 with 8.5% CAGR

April 8, 2026April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Adalimumab, Infliximab and Etanercept Biosimilars Market Evolve From 2026 To 2030?

The animal health market size has demonstrated significant growth in recent times. This market is expected to expand from $59.77 billion in 2025 to $64.45 billion in 2026, registering a compound annual growth rate (CAGR) of 7.8%. The historical expansion can be ascribed to factors like the escalating incidence of animal diseases, a growing population of companion and commercial animals, the proliferation of veterinary hospitals and clinics, the necessity for advanced diagnostic solutions, and the broadening of pharmaceutical and vaccine production.

The animal health market is poised for significant expansion in the upcoming years. This sector is expected to grow to $89.45 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 8.5%. The projected increase during this period stems from factors such as progress in genomic-based vaccines, the rise of AI-enabled diagnostics, increasing integration of feed additives, a growing focus on animal welfare, and the wider deployment of point-of-care testing devices. Dominant trends for the forecast period involve an amplified concentration on preventive animal healthcare, the expansion of companion animal wellness programs, broader availability of laboratory and point-of-care diagnostics, increasing adoption of medicinal feed additives, and the creation of herbal and nutraceutical supplements.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9893&type=smp

What Key Drivers Are Influencing The Growth Of The Adalimumab, Infliximab and Etanercept Biosimilars Market?

The rising occurrence of zoonotic diseases is expected to bolster the expansion of the animal health market in the future. These are infectious illnesses capable of spreading between various animal species and humans, or vice versa. Employing diverse strategies to monitor and protect animal well-being assists in managing zoonosis, thereby contributing to the safeguarding of public health. For example, in June 2023, the National Library of Medicine, a US-based entity operated by the United States federal government, reported that zoonotic diseases are linked to 2.5 billion human cases globally and approximately 2.7 million annual deaths. Consequently, the growing incidence of zoonotic diseases is set to drive the animal health market forward.

Which Segment Areas Are Covered In The Adalimumab, Infliximab and Etanercept Biosimilars Market Analysis?

The animal health market covered in this report is segmented –

1) By Product: Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics , Equipment And Disposables, Other Products

2) By Animal Type: Commercial, Companion

3) By Route Of Administration: Oral, Parenteral, Topical

4) By End-User: Veterinary Hospitals And Clinics, Animal Care And Rehabilitation Centers, Diagnostic Centers

Subsegments:

1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines

2) By Pharmaceuticals: Anti-Infective Agents, Anti-Inflammatory Drugs, Parasiticides, Pain Management Medications

3) By Medicinal Feed Additives: Probiotics, Prebiotics, Antimicrobials, Enzymes

4) By Diagnostics: Laboratory Diagnostic Tests, Point-Of-Care Testing Devices, Imaging Equipment

5) By Equipment And Disposables: Surgical Instruments, Monitoring Devices, Disposable Syringes And Needles

6) By Other Products: Nutraceuticals, Supplements, Herbal Medicines

What Key Developments And Trends Are Impacting The Animal Health Market?

Leading companies in the animal health market are concentrating on technological advancements, such as electronic prescription and delivery systems, to secure a competitive edge. These platforms are integrated digital solutions that allow veterinarians to generate, transmit, and manage prescriptions electronically, linking them to fulfillment services that dispatch prescribed medications directly to animal owners within a designated delivery framework, thus improving accessibility, convenience, and adherence to treatment protocols. For instance, in January 2025, PetsApp Ltd, a UK-based digital pet health platform, unveiled an expanded Prescriptions Home Delivery service. This was a collaboration with Covetrus Inc, a US-based animal health technology provider, and National Veterinary Services Limited, a UK-based company specializing in animal health services and products, offering next-day delivery of prescribed animal medications, automated refill management, and customized delivery options to suit clinic and owner preferences. This innovation enhances prompt access to vital therapies and supports clinic operations, though it may necessitate investment in digital integration and training for some practices.

Which Global Companies Are Actively Competing In The Adalimumab, Infliximab and Etanercept Biosimilars Market?

Major companies operating in the animal health market are Elanco Animal Health Incorporated, Merck Animal Health, Boehringer Ingelheim International GmbH, Heska Corporation, Vetoquinol SA, Virbac, Bayer AG, Novartis AG, Biogenesis Bago, Intervet International BV, IDEXX Laboratories Inc., Hester Biosciences Ltd., Intas Pharmaceutucals Ltd., Dechra Pharmaceuticals, Kindred Biosciences, Phibro Animal Health Corporation, Neogen Corporation, Norbrook Laboratories, Huvepharma EOOD, Abaxis Inc., ECO Animal Health Group, Hipra, Zoetis Inc., Kemin Industries, Troy Laboratories, Parnell Pharmaceuticals, Ceva Sante Animale, Bimeda Inc., Animalcare Group, PetIQ, AdvaVet Inc.

Read the full animal health market report here:

https://www.thebusinessresearchcompany.com/report/animal-health-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Adalimumab, Infliximab and Etanercept Biosimilars Market?

North America was the largest region in the animal health market in 2025. The regions covered in the animal health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Adalimumab, Infliximab and Etanercept Biosimilars Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9893&type=smp

Browse Through More Reports Similar to the Global Animal Health Market 2026, By The Business Research Company

Wildlife Health Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/wildlife-health-global-market-report

Farm Animal Healthcare Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/farm-animal-healthcare-global-market-report

Animal Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795